Search Results
Jun 09, 2026, 08:43 ET The Sausage Project Debuts in Walmart as Brand Expands to More Than 3,200 Stores Nationwide
nationwide by the end of July. The Sausage Project's fully cooked chicken sausages deliver 12–13g of protein per serving and contain 35% less fat than the leading chicken sausage. Made with a flavorful blend of both dark and white meat, the sausages contain no antibiotics, added nitrates or nitrites.
More news about: The Sausage Project
Jun 09, 2026, 07:47 ET Don't Forget to Enter the Eggland's Best x MasterChef "Ultimate Summer Entertaining Sweepstakes" Before It Ends June 30
EggsEggland's Best is the leading fortified egg brand in the U.S., providing eggs with superior nutrition such as six times more Vitamin D, 25% less saturated fat, more than double the Omega-3s, 10 times more Vitamin E, and more than double the Vitamin B12 compared to ordinary eggs. Eggland's Best's hens are fed
More news about: Eggland's Best
Jun 09, 2026, 07:00 ET Kad Bnei Darom Gives Fresh-Frozen Herbs a Makeover with a Soft, Scoopable Format
freezing-point lowering technology. This creates a soft, creamy texture that is sustained throughout freezing, without the addition of salt, sugar, or fat, and makes the herbs easy to work with even when completely frozen."Our Cuca™ frozen herbs are designed to elevate the user experience for the
More news about: Kad Bnei Darom
Jun 09, 2026, 05:13 ET Whole-Body Spatial Intelligence Beyond Weight-loss: nference Advances Cardiometabolism Moat for Precision Peptide Medicines and Healthy Longevity
Professor of Johns Hopkins.Body-composition digital phenotyping reveals that the future of GLP-1 longevity medicine must optimize fat loss without sacrificing lean-tissue reserveIn the study "Greater lean-body-mass decline with tirzepatide than semaglutide in routine care,
More news about: nference
Jun 08, 2026, 10:03 ET Power to the Patients to Host Congressional Baseball Pre-Game Concert Featuring White Ford Bronco
Fat Joe,
More news about: Power to the Patients
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
monotherapies had no significant effect on body weight, combination treatment achieved a 23.6% reduction versus control (p<0.05), with endpoint fat mass and epididymal fat weight reduced by 43.5% and 42.1%, respectively. All treatments decreased ALT, with the largest reduction rate of 83.5% in the combination
More news about: MetaVia Inc.
Jun 08, 2026, 04:30 ET 2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
in body weight and a 50% decrease in fat mass relative to control. In combination therapy, IBI3046 administered with a low dose of GLP-1RA achieved 20% body weight loss and a 80% reduction in fat mass. Combining IBI3046 with GLP-1RAs may synergistically enhance fat loss while mitigating key limitations
More news about: Innovent Biologics
Jun 08, 2026, 02:03 ET Configit er af Deloitte udnævnt til en af Danmarks bedst ledede virksomheder
konfigurerbare produkter og tjenester hurtigere og mere effektivt ud på markedet." Vi hjælper med at udnytte AI's potentiale, når virksomhederne tager fat på disse forretningskritiske digitale transformationsprojekter. Det er glædeligt at se, at vores hårde arbejde bliver anerkendt, især af en organisation
More news about: Configit
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
olezarsen, a targeted medication designed to lower dangerously high triglyceride levels in people whose bodies have trouble clearing fat from the blood. Patients with high blood fat levels (severe hypertriglyceridemia) were treated with olezarsen (at 50mg or 80mg) or placebo for 12 months. The primary endpoint
More news about: American Diabetes Association
Jun 07, 2026, 14:30 ET Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
compromising muscle mass. The treatment led to visceral fat reductions of up to 34%, targeting the metabolically harmful fat closely linked to insulin resistance, cardiovascular risk, and disease progression. Researchers also observed liver fat reductions of up to 63.1%, underscoring survodutide's potential
More news about: American Diabetes Association
Jun 07, 2026, 14:30 ET Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
characterized by abdominal fat accumulation, not only affects body shape but is also a key risk factor for type 2 diabetes, metabolic syndrome and cardiovascular diseases. While effectively reducing body weight, ecnoglutide significantly improves central obesity and local fat accumulation, optimizing body
More news about: Sciwind Biosciences Co., Ltd.
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
Across studies, women taking Foundayo saw meaningful reductions in their waist circumference, a measure associated with reduced abdominal fat and cardiometabolic riskINDIANAPOLIS, June 7, 2026
More news about: Eli Lilly and Company
Jun 06, 2026, 14:30 ET Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
naturally occurring hormones— GIP, GLP-1, and glucagon—to help reduce appetite, improve insulin response, increase energy use, and promote fat metabolism.Data from the TRANSCEND-T2D-1 and TRIUMPH-1 trials follow
More news about: American Diabetes Association
Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
Misunderstood and Difficult to Recognize DKA develops in people with diabetes when the body does not have enough insulin and begins breaking down fat for energy, causing ketones to rise to dangerous levels in the blood.2 While traditionally associated with Type 1 diabetes, DKA is increasingly
More news about: Abbott
Jun 05, 2026, 23:06 ET CST Tires Showcases Lightweight Innovation at 2026 China International Bicycle Expo
Defining a New E-BIKE AestheticCST CTC-40 BIG BOAT ALPHA: Upgraded from the popular BIG BOAT line, tailored for E-FAT bikes. Incorporates contemporary design elements for both performance and visual appeal in the urban E-BIKE market.Exhibition
More news about: CST Tires
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass and preventing post-treatment weight rebound.NEW ORLEANS,
More news about: Ractigen Therapeutics
Jun 05, 2026, 18:30 ET First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
classified as living with overweight or obesity. While insulin therapy is essential for managing blood glucose in type 1 diabetes, it can also promote fat storage and weight gain, which can increase the risk of serious complications such as heart and kidney disease, creating a significant unmet need for
More news about: American Diabetes Association
Jun 05, 2026, 08:45 ET Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx
medical appliance and technology for use in orthopedic, plastic, and cosmetic surgery procedures. IntelliFat® BOD™ successfully uses a patient's own body fat, clinically referred to as adipose tissue, to aid in patient recovery and healing in all parts of the body (joint and ligament repair). MIT is committed
More news about: Micro Imaging Technology, Inc
Jun 04, 2026, 12:00 ET Ny undersøgelse fra Apica: Agentbaseret AI forventes at udløse en 9,5-dobling af telemetridata, hvilket vil efterlade de fleste virksomheder sårbare
risici. Jeg kan ikke se, at der er tale om aftagende afkast eller en langsom nedadgående tendens i væksten i datamængden. Organisationer, der ikke tager fat på arkitekturen i deres telemetripipeline nu, vil stå over for et valg mellem to muligheder: "Enten betaler man de skyhøje omkostninger til overvågning,
More news about: Apica
Jun 04, 2026, 00:01 ET 2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership - Vital Strategies
could not be more visible. Co-hosting nations Canada and Mexico have enacted front-of-package warning labels on products with excess sugar, salt and fat—and Mexico has led the way on health taxes on sweetened beverages, along with the Canadian provinces of Newfoundland and Labrador. These measures reflect
More news about: Vital Strategies
Jun 04, 2026, 00:01 ET 2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership - Vital Strategies
could not be more visible. Co-hosting nations Canada and Mexico have enacted front-of-package warning labels on products with excess sugar, salt and fat—and Mexico has led the way on health taxes on sweetened beverages, along with the Canadian provinces of Newfoundland and Labrador. These measures reflect
More news about: Vital Strategies
Jun 03, 2026, 15:26 ET Farmer Focus Expands Nationally into Fully Cooked Category with Award-Winning Organic Chicken Line
flavorful and versatileAll four products have chef-driven flavor profiles, butcher-quality texture, and are high in protein and low in fat. This offers consumers convenient, ready-to-heat options that they can still feel good about.Before it even hit shelves, the lineup earned recognition
More news about: Farmer Focus
Jun 03, 2026, 08:03 ET Blue Diamond Almonds New Look Hits Shelves Nationwide
prove, that eating 1.5 ounces per day of most nuts, such as almonds, as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. See nutrition information for fat content.
More news about: Blue Diamond Almonds
Jun 03, 2026, 06:47 ET MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
diabetes.1 The complication occurs when the body doesn't have enough insulin to use blood sugar as energy, and instead begins breaking down fat for fuel, leading to a buildup of acid-like ketones. Ketones can rise independently of glucose levels and, in some cases, even when glucose appears in
More news about: MiniMed
Jun 02, 2026, 08:00 ET The Scale Built for the GLP-1 Era
hardest part of any weight loss journey is ensuring you lose fat, not muscle. Withings BodyFit's 6-zone analysis tracks precisely what you are losing and where with every weigh-in, including visceral fat, the metabolically active fat stored around internal organs that poses the greatest risk
More news about: Withings